Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Granzer Regulatory Consulting & Services
Munich, Bavaria, Germanygranzer.biz ↗
- Ownership
- Private
- Employees
- ~42
- Development stage
- Other
01
Overview
Granzer Regulatory Consulting & Services is an established regulatory affairs and drug development consultancy supporting pharmaceutical, biotech, and medtech companies globally through all phases of drug and device development—from early nonclinical to licensure—across all therapeutic modalities and indications[1][2][5].
- Modalities
- Small moleculeBiologicCell therapyGene therapyMonoclonal antibodyPeptidesOligonucleotide
- Industry
- Consulting
02
Partnerships
No major disclosed pharma/biotech partnerships
Beyond the preview
Go deeper on Granzer Regulatory Consulting & Services.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Granzer Regulatory Consulting & Services.